These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12481417)

  • 41. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma.
    Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD
    Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice.
    Tousignant JD; Gates AL; Ingram LA; Johnson CL; Nietupski JB; Cheng SH; Eastman SJ; Scheule RK
    Hum Gene Ther; 2000 Dec; 11(18):2493-513. PubMed ID: 11119421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
    Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
    Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases.
    Blezinger P; Freimark BD; Matar M; Wilson E; Singhal A; Min W; Nordstrom JL; Pericle F
    Hum Gene Ther; 1999 Mar; 10(5):723-31. PubMed ID: 10210140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.
    Oshikawa K; Shi F; Rakhmilevich AL; Sondel PM; Mahvi DM; Yang NS
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13351-6. PubMed ID: 10557324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
    Yin X; Yan X; Yang Q; Cao H; Liang H
    Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.
    Wigginton JM; Komschlies KL; Back TC; Franco JL; Brunda MJ; Wiltrout RH
    J Natl Cancer Inst; 1996 Jan; 88(1):38-43. PubMed ID: 8847724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers.
    Mahato RI; Lee M; Han S; Maheshwari A; Kim SW
    Mol Ther; 2001 Aug; 4(2):130-8. PubMed ID: 11482984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
    Sung MW; Chen SH; Thung SN; Zhang DY; Huang TG; Mandeli JP; Woo SL
    Hum Gene Ther; 2002 Apr; 13(6):731-43. PubMed ID: 11936972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA.
    Yamanaka R; Yajima N; Tsuchiya N; Honma J; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG
    J Neurosurg; 2002 Nov; 97(5):1184-90. PubMed ID: 12450042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
    Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
    J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
    Zou JP; Yamamoto N; Fujii T; Takenaka H; Kobayashi M; Herrmann SH; Wolf SF; Fujiwara H; Hamaoka T
    Int Immunol; 1995 Jul; 7(7):1135-45. PubMed ID: 8527411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
    Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
    J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
    Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
    Eguchi J; Hiroishi K; Ishii S; Mitamura K
    Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
    Díez S; Navarro G; de ILarduya CT
    J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
    Griffith TS; Kawakita M; Tian J; Ritchey J; Tartaglia J; Sehgal I; Thompson TC; Zhao W; Ratliff TL
    J Natl Cancer Inst; 2001 Jul; 93(13):998-1007. PubMed ID: 11438565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.